Multi-Targeting by β -Elemene and Its Anticancer Properties: A Good Choice for Oncotherapy and Radiochemotherapy Sensitization

Nutrition and Cancer
Hongxuan TongJingshang Wang

Abstract

Several studies have focused on chemical agents, tailored from natural edible products, used to prevent and treat various diseases. β-elemene is a well-known compound derived from Curcuma wenyujin that possesses a wide spectrum of anticancer properties under preclinical and clinical conditions. Several studies have demonstrated its inhibitory effect both in humans and animals with cancers. Numerous in vivo and in vitro experimental models have revealed that β-elemene can modulate multiple molecular pathways involved in carcinogenesis. In general, (1) β-elemene itself can inhibit and kill tumor cells through a variety of mechanisms, and (2) can synergistically enhance the effect of radiotherapy and/or chemotherapy, (3) also can regulate autoimmune in the treatment of tumors. In this article, we critically focused on the available scientific evidence discussing the use of β-elemene in cancer prevention, and its molecular targets and mechanisms of action in different types of cancer. In addition, we have discussed its sources, chemistry, bioavailability, and future research directions.

References

Dec 31, 2002·Lancet·Silvana PilottiFranco Zunino
Dec 6, 2003·The New England Journal of Medicine·Peter C Enzinger, Robert J Mayer
Jul 26, 2005·Biopharmaceutics & Drug Disposition·Kun WangChengye Su
Oct 14, 2005·Drug Development and Industrial Pharmacy·Yanzhi WangDianzhou Bi
Dec 21, 2005·International Ophthalmology Clinics·Agop Y Bedikian
Jan 6, 2006·The New England Journal of Medicine·Deborah K ArmstrongUNKNOWN Gynecologic Oncology Group
Apr 18, 2006·Bioorganic & Medicinal Chemistry·Liying XuJinhua Dong
Aug 1, 2006·Journal of Pain and Symptom Management·Alexander W Jahng, Solomon S Liao
Feb 19, 2008·The Thoracic and Cardiovascular Surgeon·Q JianjunL Donglei
Mar 4, 2008·Experimental Dermatology·Paul LoriganAxel Hauschild
Oct 24, 2008·The New England Journal of Medicine·Bruce R Bistrian
Oct 24, 2008·The New England Journal of Medicine·Michael A Meyer
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David S MillerCecelia H Boardman
Apr 4, 2009·The Lancet Oncology·B Ashleigh Guadagnolo, Gunar K Zagars
Dec 5, 2009·The Journal of Pharmacy and Pharmacology·Xue Shen WuHui Fang Yan
May 7, 2010·CA: a Cancer Journal for Clinicians·Erwin G Van MeirJeffrey J Olson
Jul 28, 2010·British Journal of Cancer·B Damato
Sep 22, 2010·International Journal of Nanomedicine·Zhaowu ZengTian Xie
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jul 23, 2011·Chinese Medicine·Wen TanYitao Wang
Nov 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christiane Maria Rosina ThallingerMichael Hejna
Dec 14, 2011·The Journal of Pharmacy and Pharmacology·Jing LiuYun-Peng Liu
May 4, 2012·Molecular Medicine Reports·Fazhen BaoHong Zhang
Jun 21, 2012·Cancer Metastasis Reviews·Yvette Drabsch, Peter ten Dijke
Mar 8, 2013·Cancer Prevention Research·Wungki ParkDong M Shin
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Mar 19, 2013·Cancer Cell International·Zhi-Jun DaiWen-Ying Wu

❮ Previous
Next ❯

Citations

Mar 16, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yi ChenWan Liao
Jun 3, 2021·International Journal of Molecular Sciences·Mohsen HesamiAndrew Maxwell Phineas Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.